Why Miromatrix Medical Shares Are Falling 40%

Miromatrix Medical Inc (NASDAQ: MIRO) shares are trading lower by 42.41% to $1.42 after the company announced pricing of a $10 million public offering of common stock.

Miromatrix Medical Inc (NASDAQ:MIRO) shares are trading lower by 42.41% to $1.42 after the company announced pricing of a $10 million public offering of common stock.

What Happened: The pricing of the underwritten public offering of 6,250,000 shares of common stock at a price to the public of $1.60 per share, before underwriting discounts and commissions.

See Also: CrowdStrike Stock Is Climbing Higher Today: What’s Going On?

The offering is expected to close on March 10, subject to customary closing conditions. Miromatrix has also granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of its common stock at the public offering price, less underwriting discounts and commissions.

According to data from Benzinga Pro, MIRO has a 52-week high of $5.29 and a 52-week low of $1.40.

Total
0
Shares
Related Posts
Read More

Reported Late Wednesday, WuXi Biologics And GSK Enter Into License Agreement On Multiple Novel Bi- & Multi-specific T Cell Engagers; Wuxi Biologics Will Receive An Upfront Payment Of $40M And Tiered Royalties On Net Sales

WuXi Biologics will provide an exclusive license to GSK for one preclinical bi-specific T cell engaging (TCE) antibody and the option of three additional bi-/multi-specific TCE antibodies developed using WuXi

GSK

Read More

JPMorgan CEO Shuffles Top Managers: Details

In a strategic realignment, Marianne Lake takes the helm as the sole CEO of Consumer and Community Banking, signaling a focus on operational efficiency. The bank's recent Q4 results, beating consensus with $39.943 billion in net revenue, further underpin the leadership changes as JPMorgan continues to navigate growth opportunities in a dynamic financial landscape.

JPM